KKI 5 manufacturers
- KKI-5
-
- $175.00
-
2026-04-20
- CAS:97145-43-2
- Purity:
- Supply Ability: 10g
|
| Product Name: | KKI 5 | | Synonyms: | 1G,10G,100G;L-Glutamamide, 1-acetyl-L-prolyl-L-phenylalanyl-L-arginyl-L-seryl-L-valyl- (9CI);PE 22-28 peptide;KKI-5 trifluoroacetate;KKI 5, CAS 97145-43-2;(S)-2-((3S,6S,9S,12S)-1-((S)-1-Acetylpyrrolidin-2-yl)-3-benzyl-6-(3-guanidinopropyl)-9-(hydroxymethyl)-12-isopropyl-1,4,7,10-tetraoxo-2,5,8,11-tetraazatridecan-13-amido)pentanediamide;Kininase inhibitor peptide | | CAS: | 97145-43-2 | | MF: | C35H55N11O9 | | MW: | 773.88 | | EINECS: | | | Product Categories: | | | Mol File: | 97145-43-2.mol |  |
| | KKI 5 Chemical Properties |
| density | 1.44±0.1 g/cm3(Predicted) | | pka | 12.94±0.46(Predicted) | | form | Solid | | Water Solubility | Soluble in water at 1mg/ml | | Sequence | Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 |
| | KKI 5 Usage And Synthesis |
| Uses | KKI-5 is a specific inhibitor of tissue kallikrein. KKI-5 can attenuate breast cancer cell invasion[1]. | | References | [1] Deshpande MS, et al. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392. J Med Chem. 1992 Aug 21;35(17):3094-102. DOI:10.1021/jm00095a002 |
| | KKI 5 Preparation Products And Raw materials |
|